Table 2.
Baseline mean PHDD | Post-treatment mean PHDD | PHDD Effect size for naltrexone versus placebo (Cohen’s d) | Percent decrease in Cohen’s d from COMBINE data | Baseline NHDD | Post-treatment NHDD | NHDD Effect size for naltrexone versus placebo (Cohen’s h) | Percent decrease in Cohen’s h from COMBINE data | |
---|---|---|---|---|---|---|---|---|
COMBINE data | 0.616 | 0.182 | −0.088 | − | 0.005 | 0.430 | −0.055 | − |
Simulation 1 data: | 0.526 | 0.155 | −0.089 | −1% | 0.053 | 0.502 | −0.055 | 0% |
mean = 1.24 | ||||||||
drinks | ||||||||
Simulation 2 data: | 0.482 | 0.134 | −0.084 | 5% | 0.073 | 0.546 | −0.048 | 13% |
mean = 1.41 | ||||||||
drinks | ||||||||
Simulation 3 data: | 0.435 | 0.115 | −0.078 | 11% | 0.098 | 0.589 | −0.042 | 24% |
mean = 1.59 | ||||||||
drinks | ||||||||
Simulation 4 data: | 0.389 | 0.098 | −0.073 | 17% | 0.129 | 0.632 | −0.036 | 35% |
mean = 1.77 | ||||||||
drinks | ||||||||
Simulation 5 data: | 0.344 | 0.084 | −0.065 | 26% | 0.166 | 0.672 | −0.028 | 49% |
mean = 1.95 | ||||||||
drinks | ||||||||
Simulation 6 data: | 0.303 | 0.070 | −0.056 | 36% | 0.207 | 0.710 | −0.019 | 65% |
mean = 2.14 | ||||||||
drinks |
Note: PHDD = percent heavy drinking days; NHDD = percent subjects with no heavy drinking days